CBS 2019
CBSMD教育中心
English

Congestive Heart Failure

科研文章

荐读文献

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) Mechanical circulatory support devices in advanced heart failure: 2020 and beyond Antithrombotics From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5) Readmission and Mortality After Hospitalization for Myocardial Infarction and Heart Failure Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors Dilated cardiomyopathy: so many cardiomyopathies! The conductive function of biopolymer corrects myocardial scar conduction blockage and resynchronizes contraction to prevent heart failure Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions Outcomes and Effect of Treatment According to Etiology in HFrEF An Analysis of PARADIGM-HF

Guideline2017 Aug 8;70(6):776-803

JOURNAL:J Am Coll Cardiol. Article Link

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

Yancy CW, Jessup M, Bozkurt B et al. Keywords: ACC/AHA Clinical Practice Guidelines; angioedema; angiotensin receptor blockers; angiotensin receptor-neprilysin inhibitor; angiotensin-converting enzyme inhibitors; beta blockers; ferric carboxymaltose; focused update; heart failure; hypertension; iron deficiency; ivabradine; natriuretic peptide biomarker; natriuretic peptides; sleep apnea

Full Text PDF